Nifty

:

25114.00

Sensex

:

81904.70

108.50 (0.43%)
355.97 (0.44%)

Login

Nifty
Sensex

:
:

25114.00
81904.70

108.50 (0.43%)
355.97 (0.44%)

Orchid Pharma Ltd.

Pharmaceuticals & Drugs

Rating :

37/99

BSE: 524372 | NSE: ORCHPHARMA

Watchlist

NSE BSE

710.75

12-Sep-2025

Open
High
Low
Previous Close

708.1
718.55
705.55
705.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

42599
30318633.65
1997.4
603.8

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,609.43
42.36
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,604.03
N/A
2.82

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.54
15.42
11.45

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-4.25
16.90
5.58

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
20.12

P:E (Median)

8 Years
5 Years
3 Years

-
34.36
40.73

P:BV (Average)

8 Years
5 Years
3 Years

2.29
3.21
3.74

EV:EBITDA (Average)

8 Years
5 Years
3 Years

5.05
52.11
31.61

Earnings Forecasts:

(Updated: 15-09-2025)

Description 2024 2025 2026 2027
Adj EPS 19.65 15.15 28.45 61.74
P/E Ratio 36.17 46.91 24.98 11.51
Revenue 921.93 1181.65 1644.35 2262.9
EBITDA 117.07 118.1 217.85 447.5
Net Income 99.66 91.75 169.45 368.6
ROA 6.13 0.05 0.06
P/B Ratio 2.72 2.91 2.61
ROE 7.99 6.75 10.95
FCFF -21.15 -469.38 101.56
FCFF Yield -0.58 -12.91 2.79
Net Debt 10.33 485.3 413.8 335.9
BVPS 261.06 244.29 272.64

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 172.93 244.41 -29.25% 237.48 217.10 9.39% 217.34 220.59 -1.47% 222.70 198.75 12.05%
Expenses 158.75 211.16 -24.82% 203.14 188.18 7.95% 190.98 184.68 3.41% 193.11 175.06 10.31%
EBITDA 14.18 33.25 -57.35% 34.33 28.93 18.67% 26.37 35.91 -26.57% 29.58 23.70 24.81%
EBIDTM 8.20% 13.60% 14.46% 13.32% 12.13% 16.28% 13.28% 11.92%
Other Income 15.93 7.77 105.02% 6.26 12.88 -51.40% 9.94 7.44 33.60% 7.96 8.18 -2.69%
Interest 3.26 3.47 -6.05% 3.98 3.45 15.36% 3.79 3.54 7.06% 3.30 3.80 -13.16%
Depreciation 8.65 8.44 2.49% 8.76 8.40 4.29% 8.61 9.27 -7.12% 8.63 7.84 10.08%
PBT 18.20 29.10 -37.46% 27.85 29.96 -7.04% 23.91 30.54 -21.71% 25.63 20.24 26.63%
Tax 0.00 0.00 0 0.00 -3.23 - 0.00 0.00 0 0.00 0.00 0
PAT 18.20 29.10 -37.46% 27.85 33.19 -16.09% 23.91 30.54 -21.71% 25.63 20.24 26.63%
PATM 10.52% 11.91% 11.73% 15.29% 11.00% 13.85% 11.51% 10.18%
EPS 3.59 5.74 -37.46% 5.49 6.55 -16.18% 4.72 6.02 -21.59% 5.05 3.99 26.57%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 172.93 244.41 -29.25% 237.48 217.10 9.39% 217.34 220.59 -1.47% 222.70 198.75 12.05%
Expenses 158.75 211.91 -25.09% 209.49 188.18 11.32% 190.98 185.20 3.12% 192.36 175.44 9.64%
EBITDA 14.18 32.49 -56.36% 27.98 28.92 -3.25% 26.36 35.39 -25.52% 30.34 23.31 30.16%
EBIDTM 8.20% 13.29% 11.78% 13.32% 12.13% 16.04% 13.62% 11.73%
Other Income 11.45 7.57 51.25% 3.90 13.36 -70.81% 8.49 7.62 11.42% 7.52 8.36 -10.05%
Interest 3.26 3.50 -6.86% 3.92 3.47 12.97% 3.80 3.54 7.34% 3.33 3.80 -12.37%
Depreciation 8.65 8.44 2.49% 8.87 8.42 5.34% 8.61 9.27 -7.12% 8.63 7.84 10.08%
PBT 13.71 28.12 -51.24% 19.09 30.38 -37.16% 22.45 30.19 -25.64% 25.90 20.02 29.37%
Tax 0.00 -0.15 - -0.04 -3.12 - 0.00 0.00 0 0.00 0.00 0
PAT 13.71 28.27 -51.50% 19.13 33.50 -42.90% 22.45 30.19 -25.64% 25.90 20.02 29.37%
PATM 7.93% 11.57% 8.06% 15.43% 10.33% 13.69% 11.63% 10.07%
EPS 2.94 5.79 -49.22% 4.40 6.50 -32.31% 4.10 5.80 -29.31% 5.37 3.90 37.69%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 850.45 921.93 819.37 665.90 556.97 450.69 481.21 583.65 644.17 755.36 879.34 Net Sales Growth -3.45% 12.52% 23.05% 19.56% 23.58% -6.34% -17.55% -9.40% -14.72% -14.10% Cost Of Goods Sold 492.83 544.22 484.46 384.62 314.07 229.27 200.31 278.16 330.87 367.46 419.31 Gross Profit 357.62 377.70 334.91 281.28 242.90 221.42 280.90 305.49 313.30 387.89 460.03 GP Margin 42.05% 40.97% 40.87% 42.24% 43.61% 49.13% 58.37% 52.34% 48.64% 51.35% 52.32% Total Expenditure 745.98 811.32 708.57 581.60 498.27 391.92 531.19 589.95 621.96 663.28 705.28 Power & Fuel Cost - 64.98 62.92 61.26 52.74 39.31 47.44 48.76 50.69 54.33 55.28 % Of Sales - 7.05% 7.68% 9.20% 9.47% 8.72% 9.86% 8.35% 7.87% 7.19% 6.29% Employee Cost - 86.36 69.64 65.35 60.21 64.40 71.60 79.14 82.39 75.44 82.63 % Of Sales - 9.37% 8.50% 9.81% 10.81% 14.29% 14.88% 13.56% 12.79% 9.99% 9.40% Manufacturing Exp. - 50.69 39.75 35.55 32.88 29.09 50.71 54.64 63.08 85.12 91.48 % Of Sales - 5.50% 4.85% 5.34% 5.90% 6.45% 10.54% 9.36% 9.79% 11.27% 10.40% General & Admin Exp. - 22.25 22.22 14.26 10.80 15.23 42.43 28.21 38.52 38.42 28.04 % Of Sales - 2.41% 2.71% 2.14% 1.94% 3.38% 8.82% 4.83% 5.98% 5.09% 3.19% Selling & Distn. Exp. - 24.14 23.86 14.34 20.35 11.52 6.42 7.40 14.62 35.43 21.35 % Of Sales - 2.62% 2.91% 2.15% 3.65% 2.56% 1.33% 1.27% 2.27% 4.69% 2.43% Miscellaneous Exp. - 18.67 5.72 6.22 7.22 3.10 112.29 93.64 41.79 7.07 21.35 % Of Sales - 2.03% 0.70% 0.93% 1.30% 0.69% 23.33% 16.04% 6.49% 0.94% 0.82% EBITDA 104.46 110.61 110.80 84.30 58.70 58.77 -49.98 -6.30 22.21 92.08 174.06 EBITDA Margin 12.28% 12.00% 13.52% 12.66% 10.54% 13.04% -10.39% -1.08% 3.45% 12.19% 19.79% Other Income 40.09 45.24 30.65 19.43 9.00 6.46 24.28 16.93 19.87 19.48 24.60 Interest 14.33 14.93 16.71 32.90 33.46 52.21 6.22 6.68 310.25 331.10 294.23 Depreciation 34.65 34.44 33.22 54.79 87.02 108.90 117.91 129.92 133.29 139.42 143.41 PBT 95.59 106.48 91.52 16.04 -52.77 -95.87 -149.84 -125.99 -401.47 -358.96 -238.98 Tax 0.00 0.00 -3.23 0.00 0.00 0.00 0.00 0.00 -46.19 -48.04 -17.25 Tax Rate 0.00% 0.00% -3.53% 0.00% 0.00% 0.00% 0.00% 0.00% 11.51% 9.04% 5.92% PAT 95.59 106.48 94.75 55.25 -52.77 -95.87 -149.84 -101.05 -355.28 -483.63 -274.27 PAT before Minority Interest 95.59 106.48 94.75 55.25 -52.77 -95.87 -149.84 -101.05 -355.28 -483.63 -274.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.24% 11.55% 11.56% 8.30% -9.47% -21.27% -31.14% -17.31% -55.15% -64.03% -31.19% PAT Growth -15.46% 12.38% 71.49% - - - - - - - EPS 18.85 21.00 18.69 10.90 -10.41 -18.91 -29.55 -19.93 -70.07 -95.39 -54.10

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 850.45 921.93 819.37 665.90 559.56 450.06 483.80 599.98 682.98 796.50 873.44 Net Sales Growth -3.45% 12.52% 23.05% 19.00% 24.33% -6.97% -19.36% -12.15% -14.25% -8.81% Cost Of Goods Sold 492.83 544.22 484.46 384.62 313.56 228.51 203.35 289.70 350.20 393.46 400.96 Gross Profit 357.62 377.70 334.91 281.28 246.00 221.56 280.45 310.28 332.79 403.05 472.47 GP Margin 42.05% 40.97% 40.87% 42.24% 43.96% 49.23% 57.97% 51.72% 48.73% 50.60% 54.09% Total Expenditure 751.58 811.33 708.58 581.60 504.98 399.40 514.99 611.80 658.68 709.37 702.65 Power & Fuel Cost - 64.98 62.92 61.26 52.74 39.31 47.44 48.76 50.69 54.33 55.28 % Of Sales - 7.05% 7.68% 9.20% 9.43% 8.73% 9.81% 8.13% 7.42% 6.82% 6.33% Employee Cost - 86.36 69.64 65.35 63.28 67.11 74.86 82.28 86.22 80.25 86.81 % Of Sales - 9.37% 8.50% 9.81% 11.31% 14.91% 15.47% 13.71% 12.62% 10.08% 9.94% Manufacturing Exp. - 50.69 39.75 35.55 32.88 29.10 53.25 55.98 65.65 87.40 94.33 % Of Sales - 5.50% 4.85% 5.34% 5.88% 6.47% 11.01% 9.33% 9.61% 10.97% 10.80% General & Admin Exp. - 22.25 22.22 14.26 13.03 18.34 43.67 30.72 41.49 40.99 31.10 % Of Sales - 2.41% 2.71% 2.14% 2.33% 4.08% 9.03% 5.12% 6.07% 5.15% 3.56% Selling & Distn. Exp. - 24.14 23.86 14.34 22.26 13.46 8.14 10.34 22.10 45.73 27.73 % Of Sales - 2.62% 2.91% 2.15% 3.98% 2.99% 1.68% 1.72% 3.24% 5.74% 3.17% Miscellaneous Exp. - 18.68 5.73 6.22 7.22 3.59 84.27 94.02 42.34 7.21 27.73 % Of Sales - 2.03% 0.70% 0.93% 1.29% 0.80% 17.42% 15.67% 6.20% 0.91% 0.74% EBITDA 98.86 110.60 110.79 84.30 54.58 50.66 -31.19 -11.82 24.30 87.13 170.79 EBITDA Margin 11.62% 12.00% 13.52% 12.66% 9.75% 11.26% -6.45% -1.97% 3.56% 10.94% 19.55% Other Income 31.36 34.45 31.13 19.43 9.00 15.21 24.28 16.93 20.30 19.17 24.91 Interest 14.31 14.93 16.74 32.90 33.46 52.21 6.23 6.69 310.26 331.11 294.24 Depreciation 34.76 34.55 33.24 54.79 87.02 108.92 117.93 129.94 133.31 141.02 145.27 PBT 81.15 95.56 91.95 16.04 -56.90 -95.25 -131.07 -131.52 -398.96 -365.82 -243.82 Tax -0.04 -0.19 -3.12 0.00 0.00 0.00 0.00 0.00 -46.19 -48.04 -17.25 Tax Rate -0.05% -0.20% -3.39% 0.00% 0.00% 0.00% 0.00% 0.00% 11.58% 8.92% 5.82% PAT 81.19 95.76 95.06 55.25 -56.90 -95.25 -131.07 69.41 -352.77 -490.49 -279.11 PAT before Minority Interest 81.19 95.76 95.06 55.25 -56.90 -95.25 -131.07 69.41 -352.77 -490.49 -279.11 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.55% 10.39% 11.60% 8.30% -10.17% -21.16% -27.09% 11.57% -51.65% -61.58% -31.96% PAT Growth -27.50% 0.74% 72.05% - - - - - - - EPS 16.01 18.89 18.75 10.90 -11.22 -18.79 -25.85 13.69 -69.58 -96.74 -55.05

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,324.05 1,218.32 731.96 677.95 681.34 797.83 -754.99 -674.13 -263.83 171.13 Share Capital 50.72 50.72 40.82 40.82 40.82 40.82 88.96 88.96 88.96 88.96 Total Reserves 1,273.33 1,167.60 691.15 637.14 640.52 757.01 -843.95 -763.10 -352.80 82.17 Non-Current Liabilities 135.06 124.21 164.67 222.40 442.26 518.98 1,435.53 1,904.62 2,204.95 2,475.41 Secured Loans 0.00 0.00 40.09 110.84 341.60 429.50 1,424.61 1,893.91 2,156.78 2,377.54 Unsecured Loans 131.64 120.21 108.75 97.32 85.90 74.47 0.00 0.00 0.00 0.00 Long Term Provisions 3.39 3.63 12.60 11.01 11.54 11.79 7.70 7.48 2.07 3.73 Current Liabilities 237.47 209.67 326.63 193.83 100.87 133.18 2,312.71 1,980.28 1,519.64 1,315.98 Trade Payables 170.48 179.39 129.11 120.74 68.74 60.21 269.93 326.85 403.68 353.09 Other Current Liabilities 22.03 14.15 53.09 47.25 25.76 69.72 1,343.66 958.10 476.00 285.05 Short Term Borrowings 42.60 14.05 140.95 22.84 2.84 0.00 695.49 694.29 599.52 633.62 Short Term Provisions 2.37 2.08 3.49 3.01 3.52 3.25 3.63 1.03 40.44 44.22 Total Liabilities 1,696.58 1,552.20 1,223.26 1,094.18 1,224.47 1,449.99 2,993.25 3,210.77 3,460.76 3,962.52 Net Block 613.25 616.43 573.06 583.65 670.39 857.86 1,161.35 1,291.28 1,401.71 1,540.36 Gross Block 1,328.11 1,297.02 1,220.45 1,176.26 1,175.97 1,246.98 1,424.57 1,424.57 2,893.25 2,893.19 Accumulated Depreciation 714.87 680.59 647.39 592.60 505.58 389.12 263.22 133.29 1,491.54 1,352.83 Non Current Assets 910.19 769.91 729.46 711.12 682.22 885.22 2,209.79 2,519.97 2,507.72 2,638.40 Capital Work in Progress 43.91 24.46 46.09 9.78 7.43 25.61 278.16 271.53 288.31 280.40 Non Current Investment 69.35 69.40 50.12 49.01 0.40 0.34 0.47 124.77 124.66 124.65 Long Term Loans & Adv. 183.67 59.61 60.20 68.66 3.98 1.41 759.97 822.41 685.17 680.99 Other Non Current Assets 0.02 0.02 0.00 0.01 0.01 0.00 9.84 9.98 7.88 12.00 Current Assets 786.39 782.29 493.79 369.78 542.25 564.77 783.46 690.80 953.03 1,324.12 Current Investments 0.00 0.00 0.00 0.00 15.02 0.00 0.00 0.00 0.00 0.00 Inventories 326.37 264.23 228.74 172.66 150.57 140.78 167.11 184.94 197.45 210.34 Sundry Debtors 241.83 189.37 211.91 160.23 131.96 66.38 140.73 145.06 246.42 375.44 Cash & Bank 164.28 257.23 22.34 4.21 18.97 172.32 324.17 301.04 256.04 313.11 Other Current Assets 53.91 6.80 3.64 12.86 225.74 185.29 151.45 59.75 253.12 425.23 Short Term Loans & Adv. 49.24 64.67 27.17 19.83 95.63 163.95 127.86 40.31 244.22 308.82 Net Current Assets 548.92 572.62 167.16 175.95 441.38 431.59 -1,529.25 -1,289.49 -566.61 8.14 Total Assets 1,696.58 1,552.20 1,223.25 1,080.90 1,224.47 1,449.99 2,993.25 3,210.77 3,460.75 3,962.52

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,267.29 1,169.47 688.65 647.38 652.91 765.98 -704.04 -791.76 -387.67 49.04 Share Capital 50.72 50.72 40.82 40.82 40.82 40.82 88.96 88.96 88.96 88.96 Total Reserves 1,216.57 1,118.75 647.83 606.56 612.09 725.17 -793.00 -880.72 -476.63 -39.92 Non-Current Liabilities 134.96 124.43 164.67 222.40 442.26 518.98 1,435.53 1,904.62 2,204.95 2,475.41 Secured Loans 0.00 0.22 40.09 110.84 341.60 429.50 1,424.61 1,893.91 2,156.78 2,377.54 Unsecured Loans 131.64 120.21 108.75 97.32 85.90 74.47 0.00 0.00 0.00 0.00 Long Term Provisions 3.39 3.63 12.60 11.01 11.54 11.79 7.70 7.48 2.07 3.73 Current Liabilities 285.57 259.97 371.89 240.78 142.08 174.94 2,345.54 2,012.51 1,540.72 1,337.62 Trade Payables 222.09 229.58 174.37 167.68 109.95 101.59 302.45 358.79 424.52 374.27 Other Current Liabilities 18.51 14.27 53.09 47.25 25.76 70.10 1,343.97 958.40 476.24 285.34 Short Term Borrowings 42.60 14.05 140.95 22.84 2.84 0.00 695.49 694.29 599.52 633.79 Short Term Provisions 2.37 2.08 3.49 3.01 3.52 3.25 3.63 1.03 40.44 44.22 Total Liabilities 1,687.82 1,553.87 1,225.21 1,110.56 1,237.25 1,459.90 3,077.03 3,125.37 3,358.00 3,862.07 Net Block 632.71 620.23 573.09 583.70 670.45 857.93 1,256.26 1,386.20 1,496.54 1,636.83 Gross Block 1,347.82 1,300.94 1,220.56 1,176.39 1,176.10 1,247.11 1,519.52 1,519.16 3,005.92 3,005.87 Accumulated Depreciation 715.11 680.71 647.47 592.68 505.66 389.18 263.26 132.96 1,509.38 1,369.04 Non Current Assets 880.50 763.12 724.20 712.91 687.39 890.58 2,309.57 2,446.42 2,478.86 2,610.87 Capital Work in Progress 80.71 30.67 46.46 9.78 7.43 25.61 278.16 271.53 288.31 280.40 Non Current Investment 49.67 45.82 44.44 45.49 0.40 0.34 0.47 1.07 0.96 0.81 Long Term Loans & Adv. 117.39 66.38 60.20 73.93 9.10 6.70 764.84 777.64 685.17 680.83 Other Non Current Assets 0.02 0.02 0.00 0.01 0.01 0.00 9.84 9.98 7.88 12.00 Current Assets 807.32 790.75 501.01 384.36 549.86 569.32 767.46 678.94 879.14 1,251.20 Current Investments 0.00 0.00 0.00 0.00 15.02 0.00 0.00 0.00 0.00 0.00 Inventories 326.37 264.23 228.74 172.66 152.89 141.69 169.77 193.74 211.25 241.85 Sundry Debtors 241.83 195.55 215.19 170.57 135.70 67.97 119.89 119.51 203.00 310.07 Cash & Bank 179.63 266.57 30.63 8.06 19.91 174.04 325.52 305.55 257.06 314.94 Other Current Assets 59.48 7.05 3.95 13.01 226.34 185.62 152.28 60.14 207.82 384.34 Short Term Loans & Adv. 53.97 57.36 22.50 20.07 95.87 164.05 140.27 40.31 198.36 267.62 Net Current Assets 521.75 530.78 129.12 143.58 407.78 394.39 -1,578.08 -1,333.57 -661.58 -86.42 Total Assets 1,687.82 1,553.87 1,225.21 1,097.27 1,237.25 1,459.90 3,077.03 3,125.36 3,358.00 3,862.07

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 27.48 130.73 13.39 89.57 24.36 80.42 15.18 5.58 317.68 211.30 PBT 106.48 91.52 54.19 -4.81 -117.15 -149.84 -101.05 -401.47 -445.42 -291.52 Adjustment 23.52 41.68 54.10 38.24 163.69 174.58 235.19 449.77 575.53 495.56 Changes in Working Capital -101.58 -3.22 -94.60 58.04 -27.10 45.25 -114.68 -35.68 187.56 7.26 Cash after chg. in Working capital 28.42 129.99 13.69 91.47 19.44 70.00 19.46 12.62 317.68 211.30 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.94 0.74 -0.30 -1.91 4.92 10.42 -4.28 -7.04 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -37.35 -315.81 -26.70 112.93 67.21 167.12 45.48 -27.95 -8.62 -1.23 Net Fixed Assets -50.54 -54.94 -80.50 -2.64 89.19 430.14 -6.63 1,485.46 -7.97 -2.38 Net Investments 0.05 -19.28 -1.11 -33.59 -15.08 0.13 124.30 -0.11 -0.01 0.00 Others 13.14 -241.59 54.91 149.16 -6.90 -263.15 -72.19 -1,513.30 -0.64 1.15 Cash from Financing Activity 25.44 167.07 31.17 -216.80 -164.99 -250.33 -0.30 33.39 -366.12 -286.52 Net Cash Inflow / Outflow 15.58 -18.01 17.86 -14.30 -73.42 -2.79 60.36 11.02 -57.07 -76.45 Opening Cash & Equivalents 0.29 18.31 0.45 14.75 88.17 90.97 30.60 19.58 313.11 389.57 Closing Cash & Equivalent 15.87 0.29 18.31 0.45 14.75 88.17 90.97 30.60 256.04 313.11

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 19.22 125.99 18.34 92.47 23.59 80.80 12.02 9.18 317.01 212.20 PBT 99.46 89.05 46.32 -1.95 -116.53 -131.07 69.41 -398.96 -452.28 -296.18 Adjustment 29.22 44.15 51.38 36.77 172.15 139.57 57.34 453.49 582.11 490.19 Changes in Working Capital -108.53 -7.84 -79.06 59.57 -36.96 61.89 -110.44 -38.31 187.17 18.19 Cash after chg. in Working capital 20.15 125.36 18.64 94.38 18.66 70.38 16.30 16.22 317.01 212.20 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.94 0.63 -0.30 -1.91 4.92 10.42 -4.28 -7.04 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -26.93 -312.03 -31.21 112.94 67.21 167.11 45.47 -28.06 -8.59 -1.46 Net Fixed Assets -50.54 -54.94 -80.50 -2.64 89.19 430.14 -6.63 1,485.46 -7.97 -2.38 Net Investments 0.05 -19.28 -1.11 -33.59 -15.08 0.13 124.30 -0.11 -0.01 0.00 Others 23.56 -237.81 50.40 149.17 -6.90 -263.16 -72.20 -1,513.41 -0.61 0.92 Cash from Financing Activity 25.22 167.04 31.17 -216.80 -164.99 -250.33 -0.30 33.39 -366.30 -286.36 Net Cash Inflow / Outflow 17.51 -19.00 18.29 -11.39 -74.20 -2.42 57.20 14.51 -57.88 -75.62 Opening Cash & Equivalents 3.60 22.60 4.31 15.69 89.89 92.31 35.11 20.60 314.94 390.56 Closing Cash & Equivalent 21.11 3.60 22.60 4.31 15.69 89.89 92.31 35.11 257.06 314.94

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 261.06 240.21 179.33 166.10 166.93 195.47 -84.86 -75.78 -29.66 19.24 ROA 6.56% 6.83% 4.77% -4.55% -7.17% -6.74% -3.26% -10.65% -13.03% -6.76% ROE 8.38% 9.72% 7.84% -7.76% -12.96% -699.60% 0.00% 0.00% 0.00% -89.85% ROCE 8.52% 8.96% 8.77% -1.86% -3.50% -7.48% -3.77% -3.40% -6.44% 0.08% Fixed Asset Turnover 0.70 0.65 0.56 0.47 0.37 0.36 0.41 0.30 0.26 0.31 Receivable days 85.36 89.38 101.99 95.74 80.31 78.55 89.36 110.08 148.10 136.50 Inventory Days 116.91 109.80 110.01 105.91 117.98 116.77 110.08 107.53 97.12 92.83 Payable days 117.32 116.21 118.55 110.10 102.64 113.51 182.54 192.92 181.33 144.12 Cash Conversion Cycle 84.95 82.96 93.45 91.55 95.64 81.81 16.91 24.69 63.90 85.21 Total Debt/Equity 0.13 0.11 0.45 0.40 0.66 0.71 -4.28 -4.75 -11.77 18.78 Interest Cover 8.13 6.48 2.68 -0.58 -0.84 -23.07 -14.12 -0.29 -0.61 0.01

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 249.86 230.58 168.72 158.61 159.96 187.67 -79.14 -89.00 -43.58 5.51 ROA 5.91% 6.84% 4.73% -4.85% -7.06% -5.78% 2.24% -10.88% -13.59% -7.05% ROE 7.86% 10.23% 8.27% -8.75% -13.43% -423.17% 0.00% 0.00% 0.00% -147.51% ROCE 8.05% 9.35% 9.11% -2.32% -3.53% -6.47% 3.08% -3.46% -6.93% -0.06% Fixed Asset Turnover 0.70 0.65 0.56 0.48 0.37 0.35 0.39 0.30 0.27 0.29 Receivable days 86.58 91.49 105.72 99.89 82.59 70.86 72.82 85.57 115.97 116.98 Inventory Days 116.91 109.80 110.01 106.18 119.45 117.49 110.57 107.46 102.41 101.94 Payable days 151.46 152.17 162.30 161.59 168.95 136.49 197.80 198.57 186.30 148.72 Cash Conversion Cycle 52.03 49.12 53.43 44.47 33.09 51.86 -14.40 -5.54 32.07 70.20 Total Debt/Equity 0.14 0.12 0.48 0.41 0.69 0.74 -4.59 -4.04 -8.01 65.54 Interest Cover 7.40 6.49 2.68 -0.70 -0.82 -20.04 11.38 -0.29 -0.63 -0.01

Top Investors:

quant mutual fund - quant small cap fund

invesco india smallcap fund and 6 others under same pan

kotak mahindra trustee co ltd a/c kotak multicap fund and 5 others under same pan

uti small cap fund and 3 others under same pan

Annual Reports:

News Update:

Orchid Pharma - Quarterly Results
12th Aug 2025, 15:57 PM

Read More
Orchid Pharma executes Deed of Hypothecation for Rs 142.50 crore loan facility
18th Jul 2025, 14:40 PM

The loan is for setting up the Cefiderocol Project
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback